- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate](/upload/6698/-6br-10as-ethyl-3-methyl-2-oxo-2-3-6b-7-10-10a-hexahydro-1h-pyrido-3-4-4-5-pyrrolo-1-2-3-de-quinoxaline-8-9h-carboxylate_23815.gif "(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate")
(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate
Product Name:(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1; 2,3-de]quinoxaline-8(9H)-carboxylate
Formulae hypotheticae: C17H21N3O3
Molecularis ponderis: 315.37
CAS Subcriptio Number:313369-25-4
![(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate](/upload/6698/-6br-10as-ethyl-3-methyl-2-3-6b-7-10-10a-hexahydro-1h-pyrido-3-4-4-5-pyrrolo-1-2-3-de-quinoxaline-8-9h-carboxylate_54063.gif "(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate")
(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate
Product Name:(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3- de]quinoxaline-8(9H)-carboxylate
Formulae hypotheticae: C17H23N3O2
Molecular pondus:301.38
CAS Subcriptio Number:313369-26-5
![(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3- de] quinoxaline hydrochloride](/upload/6698/-6br-10as-3-methyl-2-3-6b-7-8-9-10-10a-octahydro-1h-pyrido-3-4-4-5-pyrrolo-1-2-3-de-quinoxaline-hydrochloride_665956.gif "(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3- de] quinoxaline hydrochloride")
(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3- de] quinoxaline hydrochloride
Product Name:(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2 ,3-de] hydrochloride quinoxaline
Formulae hypotheticae: C14H20ClN3
Molecular pondus:265.79
CAS Subcriptio Number:2402752-92-3
4-Chloro-4'-fluorobutyrophenone
Product Name: 4-Chloro-4'-fluorobutyrophenone
Formulae hypotheticae: C10H10ClFO
Molecular pondus:200.64
CAS Subcriptio Number:3874-54-2
Tucatinib N-1
Product Name: Tucatinib N-1
Formulae hypotheticae: C26H26N8O2S
Molecular pondus:514.6
CAS Subcriptio Number:1429755-58-7
1-(3-cyano-4-((dimethylamino)methyleneamin
Product Name: 1-(3-cyano-4-((dimethylamino)methyleneamin
Formulae hypotheticae: C15H21N5OS
Molecularis ponderis: 319.43
CAS Registry Number: 937263-23-5
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
